Literature DB >> 19806163

Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients.

Katherine K Wynn1, Tania Crough, Scott Campbell, Keith McNeil, Andrew Galbraith, Denis J Moss, Sharon L Silins, Scott Bell, Rajiv Khanna.   

Abstract

Primary infection or recrudescence of latent virus infection in transplant recipients can be manifested either as asymptomatic or symptomatic disease. Here we show that symptomatic human cytomegalovirus (HCMV) or Epstein-Barr virus (EBV) infection or recrudescence following solid organ transplantation (SOT) was coincident with a dramatic skewing of T-cell receptor beta variable (TRBV) repertoire, with expansions of monoclonal/oligoclonal clonotypes. As the clinical symptoms resolved, the peripheral blood repertoire reverted to a more diverse distribution. In contrast, SOT recipients with asymptomatic or no viral infection or recrudescence showed minimal or no skewing of the T-cell receptor repertoire to maintain peripheral blood repertoire diversity. More importantly, we show that large monoclonal/oligoclonal repertoire expansions are associated with the loss of HCMV-specific T-cell function observed in SOT patients undergoing symptomatic viral infection or recrudescence, whereas SOT recipients who maintain peripheral blood TRBV repertoire diversity and functional antigen-specific T-cell responses can resist clinical symptomatic disease in spite of high levels of viral load.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806163     DOI: 10.1038/icb.2009.74

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  8 in total

1.  Epstein-Barr virus-specific CD8(+) T lymphocytes from diffuse large B cell lymphoma patients are functionally impaired.

Authors:  D Cárdenas; G Vélez; A Orfao; M V Herrera; J Solano; M Olaya; A M Uribe; C Saavedra; M Duarte; M Rodríguez; M López; S Fiorentino; S Quijano
Journal:  Clin Exp Immunol       Date:  2015-09-11       Impact factor: 4.330

2.  T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response.

Authors:  Corey Smith; Dillon Corvino; Leone Beagley; Sweera Rehan; Michelle A Neller; Pauline Crooks; Katherine K Matthews; Matthew Solomon; Laetitia Le Texier; Scott Campbell; Ross S Francis; Daniel Chambers; Rajiv Khanna
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

3.  Quantitative analysis of T cell receptor diversity in clinical samples of human peripheral blood.

Authors:  Sarfraz A Memon; Claude Sportès; Francis A Flomerfelt; Ronald E Gress; Frances T Hakim
Journal:  J Immunol Methods       Date:  2011-10-01       Impact factor: 2.303

4.  CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma.

Authors:  Antonio Galleu; Claudio Fozza; Maria Pina Simula; Salvatore Contini; Patrizia Virdis; Giovanna Corda; Simonetta Pardini; Francesca Cottoni; Sara Pruneddu; Antonio Angeloni; Simona Ceccarelli; Maurizio Longinotti
Journal:  Neoplasia       Date:  2012-06       Impact factor: 5.715

5.  Identification of errors introduced during high throughput sequencing of the T cell receptor repertoire.

Authors:  Phuong Nguyen; Jing Ma; Deqing Pei; Caroline Obert; Cheng Cheng; Terrence L Geiger
Journal:  BMC Genomics       Date:  2011-02-11       Impact factor: 3.969

6.  T cell mediated suppression of neurotropic coronavirus replication in neural precursor cells.

Authors:  Warren C Plaisted; Jason G Weinger; Craig M Walsh; Thomas E Lane
Journal:  Virology       Date:  2013-12-12       Impact factor: 3.616

7.  BKV Clearance Time Correlates With Exhaustion State and T-Cell Receptor Repertoire Shape of BKV-Specific T-Cells in Renal Transplant Patients.

Authors:  Ulrik Stervbo; Mikalai Nienen; Benjamin J D Weist; Leon Kuchenbecker; Jochen Hecht; Patrizia Wehler; Timm H Westhoff; Petra Reinke; Nina Babel
Journal:  Front Immunol       Date:  2019-04-10       Impact factor: 7.561

8.  Professional antigen presenting cells in human herpesvirus 8 infection.

Authors:  Emilee R Knowlton; Lauren M Lepone; Jun Li; Giovanna Rappocciolo; Frank J Jenkins; Charles R Rinaldo
Journal:  Front Immunol       Date:  2013-01-21       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.